-- 
Richter Falls to 7-Week Low on Competitor Contraceptive Approval

-- B y   A n d r a s   G e r g e l y
-- 
2011-11-29T15:46:00Z

-- http://www.bloomberg.com/news/2011-11-29/richter-falls-to-7-week-low-on-competitor-contraceptive-approval.html
Gedeon Richter Nyrt. (RICHT) , Hungary’s
largest drugmaker, fell to the lowest in seven weeks after U.S.
competitor  Watson Pharmaceuticals Inc. (WPI)  received approval from
the  Food and Drug Administration  for Vestura, a generic
contraceptive drug.  The shares of Richter, which makes the Plan B morning-after
contraceptive pill, fell 1.9 percent to 33,755 forint, the
lowest on a closing basis since Oct. 10, by 4:27 p.m. in
Budapest.  Vestura is a generic version of  Bayer AG ’s Yaz oral
contraceptive.  To contact the reporter on this story:
Andras Gergely in Budapest at 
 agergely@bloomberg.net   To contact the editor responsible for this story:
Gavin Serkin at 
 gserkin@bloomberg.net  